Physician profile
John Line
NPI 1982697553
$2,970.72
in general payments reported to CMS, 2019-2025
14 companies · $1,919 in 2025
The $1,919 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $245 · 2023: $159 · 2024: $526 · 2025: $1,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332 · Travel and Lodging: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.19 |
| Travel and Lodging | $1,271.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,808.37 | 2021-2025 | Novachor, Apligraf, Affinity |
| Davol INC. | $380.82 | 2024-2025 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $227.50 | 2021-2025 | Grafix Pl |
| Becton, Dickinson and Company | $155.45 | 2025 | Arista |
| Reapplix INC. | $108.20 | 2024 | 3c Patch Kit - Box |
| Zimmer Biomet Holdings, INC. | $87.28 | 2022 | |
| Stryker Corporation | $50.01 | 2025 | Aequalis Perform, Aequalis Perform Reversed, Aequalis Ascend Flex |
| Bioventus LLC | $33.45 | 2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Abbvie INC. | $24.75 | 2025 | |
| Solventum Corporation | $22.96 | 2025 | 3m Cavilon, Activ.A.C. |
| Ferring Pharmaceuticals INC. | $21.38 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $19.24 | 2023 | Dysport |
| Endo Pharmaceuticals INC. | $16.35 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.96 | 2023 | Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Line listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.